Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology
Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth European Journal of Cancer
Statin Treatment and Outcomes of Metastatic Pancreatic Cancer: A Pooled Analysis of Two Phase III Studies Clinical and Translational Oncology
Development and Validation of a Nomogram Prognostic Model for Patients with Advanced Non-Small-Cell Lung Cancer Cancer Informatics
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data Journal for ImmunoTherapy of Cancer
A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma Cancer Chemotherapy and Pharmacology
Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data Prostate Cancer and Prostatic Diseases
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial Prostate Cancer and Prostatic Diseases
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors Journal for ImmunoTherapy of Cancer
The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data The Oncologist
Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data Journal of Clinical Oncology
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine
Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials Expert Review of Gastroenterology and Hepatology
Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients British Journal of Clinical Pharmacology

Pages